Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

Published : Nov-2020

No. of Pages : 96

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Liver Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Liver Cancer - Pipeline Products by Stage of Development
3.2 Liver Cancer - Pipeline Products by Territory
3.3 Liver Cancer - Pipeline Products by Regulatory Path
3.4 Liver Cancer - Pipeline Products by Estimated Approval Date
3.5 Liver Cancer - Ongoing Clinical Trials
4 Liver Cancer - Pipeline Products under Development by Companies
4.1 Liver Cancer Companies - Pipeline Products by Stage of Development
4.2 Liver Cancer - Pipeline Products by Stage of Development
5 Liver Cancer Companies and Product Overview
6 Liver Cancer- Recent Developments
6.1 Sep 30, 2020: Skoltech scientists discovered a new biomarker for liver cancer diagnosis
6.2 Jul 30, 2020: Blueprint Medicines reports second quarter 2020 financial results
6.3 Jun 24, 2020: Novel radiotracer proves advantageous for imaging neuroendocrine tumor patients with liver-dominant disease
6.4 Jun 15, 2020: Study demonstrates feasibility of hologram technology in liver tumor ablation
6.5 Jun 02, 2020: Pfizer establishes new program to support continued biotechnology innovation
6.6 May 12, 2020: National Cancer Institute renews Jackson Laboratory's Cancer Center Designation
6.7 Feb 27, 2020: James Quincey elected to Pfizer's board of directors
6.8 Feb 14, 2020: Pfizer: Appointment of Mr. Samir Kazi as an executive director
6.9 Feb 14, 2020: Pfizer: Resignation of Mr. Vivek Dhariwal
6.10 Feb 13, 2020: Blueprint Medicines reports fourth quarter and full year 2019 financial results
6.11 Jan 28, 2020: Pfizer reports fourth-quarter and full-year 2019 results
6.12 Jan 27, 2020: PerkinElmer announces financial results for the fourth quarter
6.13 Jan 13, 2020: Blueprint Medicines announces 2020 corporate goals
6.14 Jan 02, 2020: Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
6.15 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members
6.16 Dec 16, 2019: Pfizer declares first-quarter 2020 dividend and announces upcoming investor day to highlight strength of innovative R&D pipeline
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Liver Cancer - Pipeline Products by Stage of Development
Table 2: Liver Cancer - Pipeline Products by Territory
Table 3: Liver Cancer - Pipeline Products by Regulatory Path
Table 4: Liver Cancer - Pipeline Products by Estimated Approval Date
Table 5: Liver Cancer - Ongoing Clinical Trials
Table 6: Liver Cancer Companies - Pipeline Products by Stage of Development
Table 7: Liver Cancer - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ARCHITECT c16000 System - PIVKA Assay - Product Status
Table 10: ARCHITECT c16000 System - PIVKA Assay - Product Description
Table 11: ARCHITECT c4000 System - PIVKA Assay - Product Status
Table 12: ARCHITECT c4000 System - PIVKA Assay - Product Description
Table 13: ARCHITECT c8000 System - PIVKA Assay - Product Status
Table 14: ARCHITECT c8000 System - PIVKA Assay - Product Description
Table 15: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status
Table 16: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description
Table 17: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status
Table 18: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description
Table 19: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status
Table 20: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description
Table 21: ARCHITECT i4000SR System - PIVKA II Assay - Product Status
Table 22: ARCHITECT i4000SR System - PIVKA II Assay - Product Description
Table 23: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Biomarker Test - Liver Cancer - Product Status
Table 25: Biomarker Test - Liver Cancer - Product Description
Table 26: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Multiplexed Detection - Des-Carboxy Prothrombin - Product Status
Table 28: Multiplexed Detection - Des-Carboxy Prothrombin - Product Description
Table 29: Multiplexed Detection - Matrix metalloproteinase 1 - Product Status
Table 30: Multiplexed Detection - Matrix metalloproteinase 1 - Product Description
Table 31: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Status
Table 32: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Description
Table 33: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Biomarker Assay - Hepatocellular Cancer - Product Status
Table 35: Biomarker Assay - Hepatocellular Cancer - Product Description
Table 36: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MBDAA Liver Cancer Test - Product Status
Table 38: MBDAA Liver Cancer Test - Product Description
Table 39: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Diagnostic Kit - Liver Cancer - Product Status
Table 41: Diagnostic Kit - Liver Cancer - Product Description
Table 42: Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
Table 43: HCC Molecular Marker Assay - Product Status
Table 44: HCC Molecular Marker Assay - Product Description
Table 45: Oxidated APO-A1 Assay - Product Status
Table 46: Oxidated APO-A1 Assay - Product Description
Table 47: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 48: DNA Biomarkers - Hepatocellular Carcinoma - Product Status
Table 49: DNA Biomarkers - Hepatocellular Carcinoma - Product Description
Table 50: Liquid Biopsy Test - Liver Cancer - Product Status
Table 51: Liquid Biopsy Test - Liver Cancer - Product Description
Table 52: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 53: RAGE Based Diagnostic Assay - Liver Cancer - Product Status
Table 54: RAGE Based Diagnostic Assay - Liver Cancer - Product Description

List of Figures
Figure 1: Liver Cancer - Pipeline Products by Stage of Development
Figure 2: Liver Cancer - Pipeline Products by Territory
Figure 3: Liver Cancer - Pipeline Products by Regulatory Path
Figure 4: Liver Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Liver Cancer - Ongoing Clinical Trials

Filed in: Diagnostics

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027 “Increasing prevalence of infectious diseases and the rising funding for R&D are driving the overall growth of the infectious disease diagnostics market” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years. “The reagents, kits, and consumables accounted for the largest market share in the infectious disease diagnostics market, by product & service, during the forecast period” The infectious disease diagnostics......	$4950
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027 “The global in vitro toxicology testing market is projected to grow at a CAGR of 10.8%.” The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%.Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market “The ADME segment is expected to account for the largest market share in 2021.” Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endp......	$4950
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027 “Rising funding for R&D in molecular diagnostics and increasing prevalence of infectious diseases and cancer are driving the overall growth of the molecular diagnostics market” The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent. “The DNA sequencing & NGS segment accounted for the highest growth rate in the molec......	$4950
Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026 “The rising an essential precondition for operational excellence and accreditation in several industries is expected to drive the overall growth of the laboratory proficiency testing market.” The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%. With proficiency testing being a mandatory procedure to be undertaken by laboratories functioning in different industries which are under regulation by organizations such as the CLIA, APLAC, and CLSI, the market for proficiency testing is expected to witness significant growth during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the gro......	$4950
Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026 “The Liquid Handling System market is projected to grow at CAGR of 5.1% from 2021 to 2026” The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported by a favorable funding scenario. However, the slow adoption of automation among small and medium-sized laboratories may restrain the market growth. “Pipettes in the product segment to witness the highest growth during the forecast period.” Based on the products, the global liquid handling system market is segmented into Pipettes, Consum......	$4950
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026 The global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the f......	$4950
Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027 “Dearth of skilled laboratory technicians” The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government p......	$4950
Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026 The organ preservation market is expected to grow at a CAGR of 6.6% in the forecast period. The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%.Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent. “The University of Wisconsin (UW) holds the largest market share in the solution market.” Based on the Solution, the segment is divided ......	$4950
Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026 The medical refrigerators market was valued at USD 3.5 Billion in 2020 and is projected to reach USD 4.9 Billion by 2026, at a CAGR of 6.0% during the forecast period. The medical refrigerators market is on course for intense growth across different end use industries such as blood banks, pharmaceutical companies, hospitals, & pharmacies, research institutes, medical laboratories, and diagnostic centers. “The ultra-low temperature freezers segment, by value, is projected to grow at the highest CAGR during the forecast period” By product type, ultra-low temperature freezers segment is expected to grow at the highest CAGR during 2021 to 2026, by value. Ultra-low temperature freezers (ULT freezers) are used for the storage of drugs, enzymes, chemicals, bacteria, viruses, cell pr......	$4950
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026 “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market gr......	$4950

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027

Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026

Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026

In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026

Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026

Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026